Issue navigation
Volume 33, Issue suppl_1, May 2018
55th ERA-EDTA CONGRESS Copenhagen Denmark May 24th - 27th 2018
Free Communication Session – Friday 25th May
a. Salt and related issues b. Cardiovascular complications in dialysis c. History of nephrology d. AKI experimental e. Clinical nephrology 1 f. CKD rehabilitation g. Clinical hypertension 1 h. Renal pathology 1 i. Biomarkers in CKD j. Bone disease in haemodialysis k. Transplantation epidemiology l. Clinical nephrology 2 m. Genetic diseases n. CKD risk and progression o. AKI clinical 1 y. Late breaking clinical trialsSupplement PDF
Full Supplement PDFPoster Session – Friday 25th May
a. Acid-base, nephrolithiasis and uric acid b. Cell signalling. Cell biology. Hormones c. Renal development and cystic diseases d. Renal pathology. Experimental and clinical 1 e. Clinical nephrology 1 f. Glomerulonephritis 1 g. AKI. Experimental h. AKI. Clinical. Epidemiology and outcome 1 i. CKD. Lab methods, GFR measurement, urine proteomics j. CKD. Pathophysiology, progression and risk factors 1 k. CKD. Clinical epidemiology 1 l. CKD. Bone disease m. Diabetes. Basic research n. Extracorporeal dialysis: techniques and adequacy 1 o. Peritoneal dialysis 1 p. Dialysis. Cardiovascular complications 1 q. Dialysis. Vascular access 1 r. Dialysis. Bone disease s. Dialysis. Epidemiology and outcome 1 t. Dialysis. Health services research u. Renal transplantation. Experimental, immune-tolerance of allogenic and xenogenic transplants v. Renal transplantation. Epidemiology and outcome 1 w. Paediatric nephrology z. Late breaking clinical trialsFree Communication Session – Saturday 26th May
a. Anaemia in CKD b. Diabetes clinical c. Transplantation treatment d. Glomerulonephritis 1 e. CKD epidemiology f. CKD-MBD g. Renal pathology 2 h. Clinical hypertension 2 i. Extracorporeal treatment j. Inflammation in CKD k. Cell biology l. Glomerulonephritis 2 m. AKI clinical 2 n. Outcome in dialysisPoster Session – Saturday 26th May
a. Genetic diseases and molecular genetics b. Renal pathology. Experimental and clinical 2 c. Hypertension. Experimental d. Hypertension. Clinical e. Clinical nephrology 2 f. Glomerulonephritis 2 g. AKI. Clinical. Epidemiology and outcome 2 h. AKI. Clinical. Prevention and treatment i. CKD. Pathophysiology, progression and risk factors 2 j. CKD. Clinical epidemiology 2 k. CKD, HD. Anaemia l. CKD. Nutrition, inflammation and oxidative stress m. CKD. Rehabilitation n. Diabetes. Clinical studies o. Extracorporeal dialysis: techniques and adequacy 2 p. Peritoneal dialysis 2 q. Dialysis. Cardiovascular complications 2 r. Dialysis. Vascular access 2 s. Dialysis. Epidemiology and outcome 2 t. Dialysis. Protein energy wasting, inflammation and oxidative stress u. Renal transplantation. Epidemiology and outcome 2 v. Renal transplantation. Treatment and immunosuppression w. History of nephrology x. Patient education research and training in nephrologyFree Communication Session – Sunday 27th May
a. Nutrition in CKD b. Vascular access c. Peritoneal dialysis d. Renal development and cystic diseases e. Acid-base and uric acid f. Diabetes basic research g. Paediatric nephrologyAdvertisement intended for healthcare professionals
Advertisement intended for healthcare professionals